
biotech


Berlin mulls genetically modified corn ban
The German government is mulling a possible ban on a specific strain of genetically modified corn because consumers and farmers are opposed to GM crops, daily Berliner Zeitung reported on Wednesday.
Boehringer Ingelheim set to buy US biotech group Actimis
The German pharmaceutical laboratory Boehringer Ingelheim said on Tuesday that it intended to buy US biotechnology specialist Actimis for up to $515 million (€330 million).